AVITA Medical Provides Preliminary Top Line Results for the Third Quarter and COVID-19 Update
Avita Medical, Inc. (RCEL)
Company Research
Source: Business Wire
VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--AVITA Medical Limited (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, today announced preliminary estimates of its top line results for the three months ended 31 March 2020, together with an operating update relating to the COVID-19 pandemic.Preliminary Estimates of Top Line Results for Three Month Period Ended 31 March 2020On a preliminary estimate basis, AVITA Medical expects its results of operations for the three months ended 31 March 2020 to reflect:Total revenue of approximately A$6.0M, an increase of A$1.0M or 21% over the A$4.9M recognized during the previous quarter.U.S. RECELL Sales of approximately US$3.9M, an increase of US$0.7M or 22% over the US$3.2M recognized during the previous quarter.*Cash totaled A$129.9M, an increase of A$5.2M from the A$124.7M reported in the previous quarter, driven largely
Show less
Read more
Impact Snapshot
Event Time:
RCEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RCEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RCEL alerts
High impacting Avita Medical, Inc. news events
Weekly update
A roundup of the hottest topics
RCEL
News
- Avita Medical (NASDAQ:RCEL) had its "hold" rating reaffirmed by analysts at Lake Street Capital.MarketBeat
- Avita Medical (NASDAQ:RCEL) had its price target lowered by analysts at D. Boral Capital from $14.00 to $10.00. They now have a "buy" rating on the stock.MarketBeat
- AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth OutlookGlobeNewswire
- AVITA Medical Announces Changes to its Board of Directors [Yahoo! Finance]Yahoo! Finance
- AVITA Medical Announces Changes to its Board of DirectorsGlobeNewswire
RCEL
Earnings
- 11/6/25 - Miss
RCEL
Sec Filings
- 1/13/26 - Form 8-K
- 1/5/26 - Form 8-K
- 11/6/25 - Form 10-Q
- RCEL's page on the SEC website